Newsroom

Judith Ng-Cashin, chief scientific officer, Clinical Solutions discusses the surge in new medicine approvals in 2017 and what this means for the biopharmaceutical industry.

BioPharma DIVE
Ned Pagiliarulo
01.03.18

Syneos Health was created in August 2017, when INC Research and inVentiv Health merged to create the only fully-integrated biopharmaceutical solutions organization. Articles below include archived media coverage from both INC Research and inVentiv Health

Format: 2018

Select any filter and click on Apply to see results

Browse Our Archives
  • 2018 0 Articles
  • 2017 0 Articles
Topics
  • Patient Recruitment 0
  • Corporate News 0
  • Pricing 0
  • CNS 0
  • Medical Devices and Diagnostics 0
  • Clinical Development 0
  • Artificial Intelligence 0
  • Predictive Analytics 0
  • Site and Patient Access 0
  • Advertising 0
  • Commercialization 0
  • Field and Sales Teams 0
  • Real World Evidence 0
  • Medical Science Liaisons 0
  • Regulatory 0
  • Reputation and Risk Management 0
  • Millennials 0
  • Europe 0
  • Rare Disease 0
  • Communications 0
  • Public Relations 0
  • Social Media 0
  • Study Start Up 0
  • Medical Affairs 0
  • Clinical Research Associates 0
  • ICH E6 (R2) 0
  • Healthcare Talent 0
  • Strategic Resourcing 0
  • Market Access 0
  • Personalized Medicine 0
  • AsiaPacific 0
  • Internet of Things 0
  • Biosimilars 0
  • Precision Medicine 0
  • Behavioral Insights 0
  • Adherence 0
  • Influencer Communications 0
  • Brand Naming 0
  • Medical Communications 0
Contact Our Media Relations Team Contact Our Team